Official name:
Adnexus Therapeutics Incorporated
Corporate Profile
Web Site:
Registration country:
United States
Industry:
Biotechnology
Company type:
A biotechnology company focused on developing new class of therapeutic compounds.
Overview
Adnexus Therapeutics is a leader in the discovery and early development of protein molecules, we call Adnectins. Adnectins are designed to either block or stimulate the action of specific proteins to fight diseases across a broad range of therapeutic areas including oncology and immunology. Their proprietary technology for engineering these proteins creates an opportunity to rapidly generate compounds for further study in a broad range of disease types.
Investors
| Investor | Profile | Amount | Stage | Date | ||
|---|---|---|---|---|---|---|
| Atlas Venture | ||||||
| Flagship Ventures VentureLabs | USD | 2002 | ||||
| One Liberty Ventures | ||||||
| Polaris Venture Partners Inc | Multistage venture capital investors with focus Technology, Healthcare and Consumer | |||||
| Venrock Associates |
Current employees
No current employees available
RECORD ID: 128534
